speb/financial-data huggingface dataset:
CTRE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 294448000.00
CTRE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 294448000.00
CTRE cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -115492000.00
CTRE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 394318000.00
CTRE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -267815000.00
CTRE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 154767000.00
CTRE cash_flow (annual, 2023-12-31) — Change In Account Payable: 2423000.00
CTRE cash_flow (annual, 2023-12-31) — Change In Payable: 2423000.00
CTRE cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 2423000.00
CTRE cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -21000.00
CTRE cash_flow (annual, 2023-12-31) — Change In Receivables: -9000.00
CTRE cash_flow (annual, 2023-12-31) — Change In Working Capital: 2393000.00
CTRE cash_flow (annual, 2023-12-31) — Changes In Cash: 281270000.00
CTRE balance_sheet (annual, 2023-12-31) — Common Stock: 1300000.00
CTRE cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -115492000.00
CTRE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1416819000.00
CTRE cash_flow (annual, 2023-12-31) — Common Stock Issuance: 634446000.00
CTRE income_statement (annual, 2023-12-31) — Cost Of Revenue: 9593000.00
CTRE balance_sheet (annual, 2023-12-31) — Current Assets: 309854000.00
CTRE balance_sheet (annual, 2023-12-31) — Current Liabilities: 70523000.00
CTRE cash_flow (annual, 2023-12-31) — Depreciation: 51257000.00
CTRE cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 50873000.00
CTRE income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 51199000.00
CTRE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 50873000.00
CTRE income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 51199000.00
CTRE income_statement (annual, 2023-12-31) — Diluted Average Shares: 106152000.00
CTRE income_statement (annual, 2023-12-31) — Diluted EPS: 0.50
CTRE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 53335000.00
CTRE balance_sheet (annual, 2023-12-31) — Dividends Payable: 36531000.00
CTRE income_statement (annual, 2023-12-31) — EBIT: 94605000.00
CTRE income_statement (annual, 2023-12-31) — EBITDA: 145804000.00
CTRE cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
CTRE cash_flow (annual, 2023-12-31) — End Cash Position: 294448000.00
CTRE cash_flow (annual, 2023-12-31) — Financing Cash Flow: 394318000.00
CTRE cash_flow (annual, 2023-12-31) — Free Cash Flow: 143791000.00
CTRE cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 4267000.00
CTRE income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -4267000.00
CTRE income_statement (annual, 2023-12-31) — General And Administrative Expense: 20897000.00
CTRE balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 5283000.00
CTRE income_statement (annual, 2023-12-31) — Gross Profit: 189006000.00
CTRE income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 36301000.00
CTRE income_statement (annual, 2023-12-31) — Interest Expense: 40883000.00
CTRE income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 40883000.00
CTRE income_statement (annual, 2023-12-31) — Interest Income: 19171000.00
CTRE income_statement (annual, 2023-12-31) — Interest Income Non Operating: 19171000.00
CTRE cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 40028000.00
CTRE balance_sheet (annual, 2023-12-31) — Invested Capital: 2012417000.00
CTRE cash_flow (annual, 2023-12-31) — Investing Cash Flow: -267815000.00
CTRE balance_sheet (annual, 2023-12-31) — Investment Properties: 1742204000.00
CTRE cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 634446000.00
CTRE cash_flow (annual, 2023-12-31) — Issuance Of Debt: 185000000.00
CTRE balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
CTRE balance_sheet (annual, 2023-12-31) — Long Term Debt: 595598000.00
CTRE balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 595598000.00
CTRE cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 185000000.00
CTRE cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -310000000.00
CTRE balance_sheet (annual, 2023-12-31) — Minority Interest: 1898000.00
CTRE income_statement (annual, 2023-12-31) — Minority Interests: 13000.00
CTRE cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 634446000.00
CTRE balance_sheet (annual, 2023-12-31) — Net Debt: 301150000.00
CTRE income_statement (annual, 2023-12-31) — Net Income: 53735000.00
CTRE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 53335000.00
CTRE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 53722000.00
CTRE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 53735000.00
CTRE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 53735000.00
CTRE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 53722000.00
CTRE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 53722000.00
CTRE income_statement (annual, 2023-12-31) — Net Interest Income: -21712000.00
CTRE cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: -251257000.00
CTRE cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -1782000.00
CTRE cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -125000000.00
CTRE cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -125000000.00
CTRE income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -21712000.00
CTRE cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 364000.00
CTRE cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -3800000.00
CTRE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -10976000.00
CTRE cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -125000000.00
CTRE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1411536000.00
CTRE balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 4160000.00
CTRE income_statement (annual, 2023-12-31) — Normalized EBITDA: 186372000.00
CTRE income_statement (annual, 2023-12-31) — Normalized Income: 94303000.00
CTRE cash_flow (annual, 2023-12-31) — Operating Cash Flow: 154767000.00
CTRE cash_flow (annual, 2023-12-31) — Operating Gains Losses: 4267000.00
CTRE income_statement (annual, 2023-12-31) — Operating Income: 116002000.00
CTRE income_statement (annual, 2023-12-31) — Operating Revenue: 198599000.00
CTRE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 129992796.00
CTRE income_statement (annual, 2023-12-31) — Other Gand A: 10394000.00
CTRE income_statement (annual, 2023-12-31) — Other Income Expense: -40568000.00
CTRE balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 5283000.00
CTRE cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2058000.00
CTRE balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 23337000.00
CTRE income_statement (annual, 2023-12-31) — Other Taxes: 908000.00
CTRE income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 400000.00
CTRE balance_sheet (annual, 2023-12-31) — Payables: 70523000.00
CTRE balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 70523000.00
CTRE balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CTRE income_statement (annual, 2023-12-31) — Pretax Income: 53722000.00
CTRE cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 0.00
CTRE cash_flow (annual, 2023-12-31) — Purchase Of Investment: -1782000.00
CTRE cash_flow (annual, 2023-12-31) — Purchase Of Investment Properties: -294095000.00
CTRE cash_flow (annual, 2023-12-31) — Purchase Of PPE: -10976000.00
CTRE balance_sheet (annual, 2023-12-31) — Receivables: 395000.00
CTRE income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 9919000.00
CTRE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 50873000.00
CTRE cash_flow (annual, 2023-12-31) — Repayment Of Debt: -310000000.00
CTRE income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
CTRE balance_sheet (annual, 2023-12-31) — Retained Earnings: -467628000.00
CTRE income_statement (annual, 2023-12-31) — Salaries And Wages: 10503000.00
CTRE cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 42838000.00
CTRE income_statement (annual, 2023-12-31) — Selling General And Administration: 20897000.00
CTRE balance_sheet (annual, 2023-12-31) — Share Issued: 129992796.00
CTRE cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 185000000.00
CTRE cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -310000000.00
CTRE income_statement (annual, 2023-12-31) — Special Income Charges: -36301000.00
CTRE cash_flow (annual, 2023-12-31) — Stock Based Compensation: 5153000.00
CTRE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1416819000.00
CTRE balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1411536000.00
CTRE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CTRE income_statement (annual, 2023-12-31) — Tax Provision: 0.00
CTRE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CTRE balance_sheet (annual, 2023-12-31) — Total Assets: 2084838000.00
CTRE balance_sheet (annual, 2023-12-31) — Total Capitalization: 2012417000.00
CTRE balance_sheet (annual, 2023-12-31) — Total Debt: 595598000.00
CTRE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1418717000.00
CTRE income_statement (annual, 2023-12-31) — Total Expenses: 82597000.00
CTRE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 666121000.00
CTRE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1774984000.00
CTRE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 595598000.00
CTRE income_statement (annual, 2023-12-31) — Total Unusual Items: -40568000.00
CTRE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -40568000.00
CTRE balance_sheet (annual, 2023-12-31) — Working Capital: 239331000.00
CTRE cash_flow (quarterly, 2024-09-30) — Common Stock Dividend Paid: -44721000.00
CTRE cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: -275000000.00
CTRE cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: -43000000.00
CTRE income_statement (quarterly, 2024-09-30) — Other Special Charges: 657000.00
CTRE cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: -275000000.00
CTRE income_statement (annual, 2024-12-31) — +Operating Expense: 90654000.00
CTRE income_statement (annual, 2024-12-31) — +Total Revenue: 228261000.00
CTRE balance_sheet (annual, 2024-12-31) — Accounts Payable: 56318000.00
CTRE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 1174000.00
CTRE balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 281000.00
CTRE balance_sheet (quarterly, 2024-12-31) — Accrued Interest Receivable: 281000.00
CTRE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 3439117000.00
CTRE cash_flow (annual, 2024-12-31) — Amortization Cash Flow: -2863000.00
CTRE cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: -2863000.00
CTRE cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 42225000.00
CTRE cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 5353000.00
CTRE balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 57261000.00
CTRE balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 57261000.00
CTRE income_statement (annual, 2024-12-31) — Basic Average Shares: 154795000.00
CTRE income_statement (annual, 2024-12-31) — Basic EPS: 0.81
CTRE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 294448000.00
CTRE cash_flow (annual, 2024-12-31) — Capital Expenditure: -8054000.00
CTRE balance_sheet (annual, 2024-12-31) — Capital Stock: 1870000.00
CTRE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 213822000.00
CTRE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 213822000.00
CTRE cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -172165000.00
CTRE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 1188806000.00
CTRE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -1513683000.00
CTRE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 244251000.00
CTRE cash_flow (annual, 2024-12-31) — Change In Account Payable: 24045000.00
CTRE cash_flow (annual, 2024-12-31) — Change In Payable: 24045000.00
CTRE cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 24045000.00
CTRE cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -3719000.00
CTRE cash_flow (annual, 2024-12-31) — Change In Receivables: -808000.00
CTRE cash_flow (annual, 2024-12-31) — Change In Working Capital: 19518000.00
CTRE cash_flow (annual, 2024-12-31) — Changes In Cash: -80626000.00
CTRE balance_sheet (annual, 2024-12-31) — Common Stock: 1870000.00
CTRE cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -172165000.00
CTRE cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: -49721000.00
CTRE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2908417000.00
CTRE cash_flow (annual, 2024-12-31) — Common Stock Issuance: 1552894000.00
CTRE income_statement (annual, 2024-12-31) — Cost Of Revenue: 13552000.00
CTRE balance_sheet (annual, 2024-12-31) — Current Assets: 368261000.00
CTRE balance_sheet (annual, 2024-12-31) — Current Liabilities: 110706000.00
CTRE cash_flow (annual, 2024-12-31) — Depreciation: 56932000.00
CTRE cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 54069000.00
CTRE income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 56831000.00
CTRE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 54069000.00
CTRE income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 56831000.00
CTRE income_statement (annual, 2024-12-31) — Diluted Average Shares: 155167000.00
CTRE income_statement (annual, 2024-12-31) — Diluted EPS: 0.80
CTRE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 124635000.00
CTRE balance_sheet (annual, 2024-12-31) — Dividends Payable: 54388000.00
CTRE income_statement (annual, 2024-12-31) — EBIT: 154709000.00
CTRE income_statement (annual, 2024-12-31) — EBITDA: 211540000.00
CTRE cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
CTRE cash_flow (annual, 2024-12-31) — End Cash Position: 213822000.00
CTRE cash_flow (annual, 2024-12-31) — Financing Cash Flow: 1188806000.00
CTRE cash_flow (annual, 2024-12-31) — Free Cash Flow: 236197000.00
CTRE cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -6837000.00
CTRE income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 6837000.00
CTRE balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CTRE balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CTRE income_statement (annual, 2024-12-31) — General And Administrative Expense: 27904000.00
CTRE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 4388000.00
CTRE income_statement (annual, 2024-12-31) — Gross Profit: 214709000.00
CTRE income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 42225000.00
CTRE income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 5353000.00
CTRE income_statement (annual, 2024-12-31) — Interest Expense: 30310000.00
CTRE income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 30310000.00
CTRE income_statement (annual, 2024-12-31) — Interest Income: 68025000.00
CTRE income_statement (annual, 2024-12-31) — Interest Income Non Operating: 68025000.00
CTRE cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 27933000.00
CTRE balance_sheet (annual, 2024-12-31) — Invested Capital: 3305344000.00
CTRE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1513683000.00
CTRE balance_sheet (annual, 2024-12-31) — Investment Properties: 3017555000.00
CTRE cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 1552894000.00
CTRE cash_flow (annual, 2024-12-31) — Issuance Of Debt: 75000000.00
CTRE balance_sheet (annual, 2024-12-31) — Long Term Debt: 396927000.00
CTRE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 396927000.00
CTRE cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 75000000.00
CTRE cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -275000000.00
CTRE cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
CTRE balance_sheet (annual, 2024-12-31) — Minority Interest: 20966000.00
CTRE income_statement (annual, 2024-12-31) — Minority Interests: 681000.00
CTRE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 1552894000.00
CTRE balance_sheet (annual, 2024-12-31) — Net Debt: 183105000.00
CTRE income_statement (annual, 2024-12-31) — Net Income: 125080000.00
CTRE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 124635000.00
CTRE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 124399000.00
CTRE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 125080000.00
CTRE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 125080000.00
CTRE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 124399000.00
CTRE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 124399000.00
CTRE income_statement (annual, 2024-12-31) — Net Interest Income: 37715000.00
CTRE cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: -1352739000.00
CTRE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -52000000.00
CTRE cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -200000000.00
CTRE cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -200000000.00
CTRE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 37715000.00
CTRE cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 8077000.00
CTRE cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -100890000.00
CTRE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -8054000.00
CTRE cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
CTRE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2904029000.00
CTRE balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 11204000.00
CTRE income_statement (annual, 2024-12-31) — Normalized EBITDA: 248911000.00
CTRE income_statement (annual, 2024-12-31) — Normalized Income: 162451000.00
CTRE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 244251000.00
CTRE cash_flow (annual, 2024-12-31) — Operating Gains Losses: -6555000.00
CTRE income_statement (annual, 2024-12-31) — Operating Income: 124055000.00
CTRE income_statement (annual, 2024-12-31) — Operating Revenue: 228261000.00
CTRE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 186993010.00
CTRE income_statement (annual, 2024-12-31) — Other Gand A: 12075000.00
CTRE income_statement (annual, 2024-12-31) — Other Income Expense: -37371000.00
CTRE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 4388000.00
CTRE cash_flow (annual, 2024-12-31) — Other Non Cash Items: -435000.00
CTRE balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 35608000.00
CTRE income_statement (annual, 2024-12-31) — Other Operating Expenses: 4900000.00
CTRE balance_sheet (annual, 2024-12-31) — Other Receivables: 95723000.00
CTRE income_statement (annual, 2024-12-31) — Other Special Charges: 657000.00
CTRE income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
CTRE income_statement (annual, 2024-12-31) — Other Taxes: 1019000.00
CTRE income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 445000.00
CTRE balance_sheet (annual, 2024-12-31) — Payables: 110706000.00
CTRE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 110706000.00
CTRE balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CTRE income_statement (annual, 2024-12-31) — Pretax Income: 124399000.00
CTRE cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 4900000.00
CTRE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -52000000.00
CTRE cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: -1371190000.00
CTRE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -8054000.00
CTRE balance_sheet (annual, 2024-12-31) — Receivables: 97178000.00
CTRE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 16314000.00
CTRE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 54069000.00
CTRE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -275000000.00
CTRE cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
CTRE income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 1326000.00
CTRE balance_sheet (annual, 2024-12-31) — Retained Earnings: -532570000.00
CTRE income_statement (annual, 2024-12-31) — Salaries And Wages: 15829000.00
CTRE cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 18451000.00
CTRE income_statement (annual, 2024-12-31) — Selling General And Administration: 27904000.00
CTRE balance_sheet (annual, 2024-12-31) — Share Issued: 186993010.00
CTRE cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
CTRE cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
CTRE income_statement (annual, 2024-12-31) — Special Income Charges: -44208000.00
CTRE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 6130000.00
CTRE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2908417000.00
CTRE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2904029000.00
CTRE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CTRE income_statement (annual, 2024-12-31) — Tax Provision: 0.00
CTRE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CTRE balance_sheet (annual, 2024-12-31) — Total Assets: 3437016000.00
CTRE balance_sheet (annual, 2024-12-31) — Total Capitalization: 3305344000.00
CTRE balance_sheet (annual, 2024-12-31) — Total Debt: 396927000.00
CTRE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2929383000.00
CTRE income_statement (annual, 2024-12-31) — Total Expenses: 104206000.00
CTRE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 507633000.00
CTRE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 3068755000.00
CTRE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 396927000.00
CTRE income_statement (annual, 2024-12-31) — Total Other Finance Cost: 1326000.00
CTRE income_statement (annual, 2024-12-31) — Total Unusual Items: -37371000.00
CTRE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -37371000.00
CTRE balance_sheet (annual, 2024-12-31) — Working Capital: 257555000.00
CTRE income_statement (quarterly, 2025-03-31) — +Operating Expense: 26864000.00
CTRE income_statement (quarterly, 2025-03-31) — +Total Revenue: 71646000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 51069000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1954000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 905000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 3455256000.00
CTRE cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: -877000.00
CTRE cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: -877000.00
CTRE cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
CTRE balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 16736000.00
CTRE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 187152000.00
CTRE income_statement (quarterly, 2025-03-31) — Basic EPS: 0.35
CTRE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 213822000.00
CTRE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -2276000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1877000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 26510000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 26510000.00
CTRE cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -54388000.00
CTRE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 383216000.00
CTRE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -35910000.00
CTRE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 71382000.00
CTRE cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -4323000.00
CTRE cash_flow (quarterly, 2025-03-31) — Change In Payable: -4323000.00
CTRE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -4323000.00
CTRE cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -3451000.00
CTRE cash_flow (quarterly, 2025-03-31) — Change In Receivables: -788000.00
CTRE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -8562000.00
CTRE cash_flow (quarterly, 2025-03-31) — Changes In Cash: 418688000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Common Stock: 1877000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2927312000.00
CTRE cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 15562000.00
CTRE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2170000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Current Assets: 747828000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 114122000.00
CTRE cash_flow (quarterly, 2025-03-31) — Depreciation: 17865000.00
CTRE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 16988000.00
CTRE income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 17841000.00
CTRE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 16988000.00
CTRE income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 17841000.00
CTRE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 187416000.00
CTRE income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.35
CTRE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 65619000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 63053000.00
CTRE income_statement (quarterly, 2025-03-31) — EBIT: 71862000.00
CTRE income_statement (quarterly, 2025-03-31) — EBITDA: 89703000.00
CTRE cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
CTRE cash_flow (quarterly, 2025-03-31) — End Cash Position: 632510000.00
CTRE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 383216000.00
CTRE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 69106000.00
CTRE cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -5163000.00
CTRE income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 5163000.00
CTRE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 8805000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 4083000.00
CTRE income_statement (quarterly, 2025-03-31) — Gross Profit: 69476000.00
CTRE income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 0.00
CTRE income_statement (quarterly, 2025-03-31) — Interest Expense: 6669000.00
CTRE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 6669000.00
CTRE income_statement (quarterly, 2025-03-31) — Interest Income: 24975000.00
CTRE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 24975000.00
CTRE cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 450000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3749461000.00
CTRE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -35910000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Investment Properties: 3047995000.00
CTRE cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 15562000.00
CTRE cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 425000000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 822149000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 822149000.00
CTRE cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 425000000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Minority Interest: 20865000.00
CTRE income_statement (quarterly, 2025-03-31) — Minority Interests: 609000.00
CTRE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 15562000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Net Debt: 795639000.00
CTRE income_statement (quarterly, 2025-03-31) — Net Income: 65802000.00
CTRE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 65619000.00
CTRE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 65193000.00
CTRE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 65802000.00
CTRE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 65802000.00
CTRE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 65193000.00
CTRE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 65193000.00
CTRE income_statement (quarterly, 2025-03-31) — Net Interest Income: 18306000.00
CTRE cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: -2150000.00
CTRE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 425000000.00
CTRE cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 425000000.00
CTRE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 18306000.00
CTRE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -2958000.00
CTRE cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -31484000.00
CTRE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -2276000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2923229000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 10652000.00
CTRE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 85428000.00
CTRE income_statement (quarterly, 2025-03-31) — Normalized Income: 61527000.00
CTRE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 71382000.00
CTRE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -5163000.00
CTRE income_statement (quarterly, 2025-03-31) — Operating Income: 42612000.00
CTRE income_statement (quarterly, 2025-03-31) — Operating Revenue: 71646000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 187669948.00
CTRE income_statement (quarterly, 2025-03-31) — Other Gand A: 3671000.00
CTRE income_statement (quarterly, 2025-03-31) — Other Income Expense: 4275000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 4083000.00
CTRE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -983000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 73890000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Other Receivables: 95723000.00
CTRE income_statement (quarterly, 2025-03-31) — Other Taxes: 218000.00
CTRE income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 183000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Payables: 114122000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 114122000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CTRE income_statement (quarterly, 2025-03-31) — Pretax Income: 65193000.00
CTRE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment Properties: -46551000.00
CTRE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -2276000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Receivables: 98582000.00
CTRE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3023000.00
CTRE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 16988000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 606000000.00
CTRE income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 888000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -529821000.00
CTRE income_statement (quarterly, 2025-03-31) — Salaries And Wages: 5134000.00
CTRE cash_flow (quarterly, 2025-03-31) — Sale Of Investment Properties: 44401000.00
CTRE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 8805000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Share Issued: 187669948.00
CTRE income_statement (quarterly, 2025-03-31) — Special Income Charges: -888000.00
CTRE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3909000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2927312000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2923229000.00
CTRE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CTRE income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
CTRE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CTRE balance_sheet (quarterly, 2025-03-31) — Total Assets: 3884448000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3749461000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Total Debt: 822149000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2948177000.00
CTRE income_statement (quarterly, 2025-03-31) — Total Expenses: 29034000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 936271000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3136620000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 822149000.00
CTRE income_statement (quarterly, 2025-03-31) — Total Unusual Items: 4275000.00
CTRE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 4275000.00
CTRE balance_sheet (quarterly, 2025-03-31) — Working Capital: 633706000.00
CTRE income_statement (quarterly, 2025-06-30) — +Operating Expense: 33764000.00
CTRE income_statement (quarterly, 2025-06-30) — +Total Revenue: 86033000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 109073000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2687000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 3807882000.00
CTRE cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: -925000.00
CTRE cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: -925000.00
CTRE cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
CTRE balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 55166000.00
CTRE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 192444000.00
CTRE income_statement (quarterly, 2025-06-30) — Basic EPS: 0.36
CTRE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 632510000.00
CTRE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -4507000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1997000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 306051000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 306051000.00
CTRE cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -63052000.00
CTRE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 361843000.00
CTRE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -789396000.00
CTRE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 100775000.00
CTRE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 7583000.00
CTRE cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 2992000.00
CTRE cash_flow (quarterly, 2025-06-30) — Change In Receivables: 1361000.00
CTRE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 11936000.00
CTRE cash_flow (quarterly, 2025-06-30) — Changes In Cash: -326778000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Common Stock: 1997000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3300532000.00
CTRE cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 349720000.00
CTRE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 3055000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Current Assets: 461234000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 176174000.00
CTRE cash_flow (quarterly, 2025-06-30) — Depreciation: 21257000.00
CTRE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 20332000.00
CTRE income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 21215000.00
CTRE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 20332000.00
CTRE income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 21215000.00
CTRE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 192851000.00
CTRE income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.35
CTRE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 68359000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 67101000.00
CTRE income_statement (quarterly, 2025-06-30) — EBIT: 81970000.00
CTRE income_statement (quarterly, 2025-06-30) — EBITDA: 103185000.00
CTRE cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 319000.00
CTRE cash_flow (quarterly, 2025-06-30) — End Cash Position: 306051000.00
CTRE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 361843000.00
CTRE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 96268000.00
CTRE cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -1968000.00
CTRE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 6381000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 19029000.00
CTRE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 12079000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 39268000.00
CTRE income_statement (quarterly, 2025-06-30) — Gross Profit: 82978000.00
CTRE income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
CTRE income_statement (quarterly, 2025-06-30) — Interest Expense: 13038000.00
CTRE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 13038000.00
CTRE income_statement (quarterly, 2025-06-30) — Interest Income: 26436000.00
CTRE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 26436000.00
CTRE cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 15942000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 4455912000.00
CTRE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -789396000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Investment Properties: 4057656000.00
CTRE cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 349720000.00
CTRE cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 600000000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1155380000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1155380000.00
CTRE cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 600000000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Minority Interest: 24445000.00
CTRE income_statement (quarterly, 2025-06-30) — Minority Interests: 643000.00
CTRE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 349720000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Net Debt: 849329000.00
CTRE income_statement (quarterly, 2025-06-30) — Net Income: 68545000.00
CTRE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 68359000.00
CTRE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 67902000.00
CTRE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 68545000.00
CTRE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 68545000.00
CTRE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 67902000.00
CTRE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 67902000.00
CTRE income_statement (quarterly, 2025-06-30) — Net Interest Income: 13398000.00
CTRE cash_flow (quarterly, 2025-06-30) — Net Investment Properties Purchase And Sale: -773495000.00
CTRE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 75000000.00
CTRE cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 75000000.00
CTRE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 13398000.00
CTRE cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 175000.00
CTRE cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 18606000.00
CTRE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -4507000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 3261264000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 9958000.00
CTRE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 96865000.00
CTRE income_statement (quarterly, 2025-06-30) — Normalized Income: 62319435.10
CTRE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 100775000.00
CTRE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -1968000.00
CTRE income_statement (quarterly, 2025-06-30) — Operating Income: 49214000.00
CTRE income_statement (quarterly, 2025-06-30) — Operating Revenue: 86033000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 199746343.00
CTRE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 19029000.00
CTRE income_statement (quarterly, 2025-06-30) — Other Gand A: 5629000.00
CTRE income_statement (quarterly, 2025-06-30) — Other Income Expense: 6320000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 39268000.00
CTRE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -453000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 88415000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Other Receivables: 97330000.00
CTRE income_statement (quarterly, 2025-06-30) — Other Taxes: 470000.00
CTRE income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 186000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Payables: 176174000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 176174000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CTRE income_statement (quarterly, 2025-06-30) — Pretax Income: 68932000.00
CTRE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment Properties: -773495000.00
CTRE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -4507000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Receivables: 100017000.00
CTRE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 3938000.00
CTRE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 20332000.00
CTRE income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 61000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -528376000.00
CTRE income_statement (quarterly, 2025-06-30) — Salaries And Wages: 6450000.00
CTRE cash_flow (quarterly, 2025-06-30) — Sale Of Investment Properties: 0.00
CTRE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 12079000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Share Issued: 199746343.00
CTRE income_statement (quarterly, 2025-06-30) — Special Income Charges: -61000.00
CTRE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3026000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3300532000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 3261264000.00
CTRE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 94435.10
CTRE income_statement (quarterly, 2025-06-30) — Tax Provision: 1030000.00
CTRE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.01
CTRE balance_sheet (quarterly, 2025-06-30) — Total Assets: 4656531000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 4455912000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Total Debt: 1155380000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3324977000.00
CTRE income_statement (quarterly, 2025-06-30) — Total Expenses: 36819000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1331554000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 4195297000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1155380000.00
CTRE income_statement (quarterly, 2025-06-30) — Total Unusual Items: 6320000.00
CTRE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 6320000.00
CTRE balance_sheet (quarterly, 2025-06-30) — Working Capital: 285060000.00
CTRE income_statement (quarterly, 2025-09-30) — +Operating Expense: 42113000.00
CTRE income_statement (quarterly, 2025-09-30) — +Total Revenue: 104265000.00
CTRE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 103109000.00
CTRE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 7389000.00
CTRE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 4516509000.00
CTRE cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: -4771000.00
CTRE cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: -4771000.00
CTRE cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 452000.00
CTRE balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 28143000.00
CTRE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 211746000.00
CTRE income_statement (quarterly, 2025-09-30) — Basic EPS: 0.35
CTRE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 306051000.00
CTRE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -3230000.00
CTRE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2227000.00
CTRE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 712480000.00
CTRE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 712480000.00
CTRE cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -67102000.00
CTRE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 381243000.00
CTRE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -75742000.00
CTRE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 100912000.00
CTRE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 9064000.00
CTRE cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -307000.00
CTRE cash_flow (quarterly, 2025-09-30) — Change In Receivables: -1334000.00
CTRE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 7423000.00
CTRE cash_flow (quarterly, 2025-09-30) — Changes In Cash: 406413000.00
CTRE balance_sheet (quarterly, 2025-09-30) — Common Stock: 2227000.00
CTRE cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -67102000.00
CTRE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3994166000.00
CTRE cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 706364000.00
CTRE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2605000.00
CTRE balance_sheet (quarterly, 2025-09-30) — Current Assets: 846066000.00
CTRE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 177915000.00
CTRE cash_flow (quarterly, 2025-09-30) — Depreciation: 26737000.00
CTRE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 21966000.00
CTRE income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 26693000.00